Patents by Inventor Ganesh D. Kini

Ganesh D. Kini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phosphonate compounds
    Patent number: 8309565
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: August 29, 2011
    Date of Patent: November 13, 2012
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate Compounds
    Publication number: 20120058975
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Application
    Filed: August 29, 2011
    Publication date: March 8, 2012
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 8008308
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: August 30, 2011
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 7790703
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: September 7, 2010
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate Compounds
    Publication number: 20100173870
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Application
    Filed: February 5, 2010
    Publication date: July 8, 2010
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 7687480
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: March 30, 2010
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Prodrugs of pharmaceuticals with improved bioavailability
    Patent number: 7517858
    Abstract: Lipid prodrugs of pharmaceutical agents and their analogs that have increased anticancer, anti-viral, anti-inflammatory, anti-proliferative activity over the parent drug, and methods for making lipid prodrugs. Compositions comprising lipid prodrugs for treating disease and methods for treating disease which involve using the compositions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 14, 2009
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, Ganesh D. Kini, James R. Beadle
  • Phosphonate compounds
    Patent number: 7452898
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: November 18, 2008
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 7098197
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: August 29, 2006
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 7094772
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: August 22, 2006
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 7034014
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Grant
    Filed: January 15, 2004
    Date of Patent: April 25, 2006
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Publication number: 20040127735
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Application
    Filed: January 15, 2004
    Publication date: July 1, 2004
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Phosphonate compounds
    Patent number: 6716825
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorder, e.g., osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like.
    Type: Grant
    Filed: November 6, 2002
    Date of Patent: April 6, 2004
    Assignee: The Regents of the University of California
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Antiviral compounds and methods of administration
    Patent number: 6686462
    Abstract: The invention provides lipophilic phosphonoacid/nucleoside conjugates that exhibit exceptional antiviral activity, including activity against drug-resistant HIV strains. Compounds of the invention include phosphonoacid/nucleoside conjugates where the carboxyl group and phosphonyl groups of the phosphonacid are esterified whereby the compound contains at least one lipophilic group and at least one nucleoside group.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: February 3, 2004
    Assignees: The Regents of the University of California, Dana-Farber Cancer Institute, Inc.
    Inventors: Andre Rosowsky, Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini, Douglas D. Richman
  • PHOSPHONATE COMPOUNDS
    Publication number: 20040019232
    Abstract: The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.
    Type: Application
    Filed: November 6, 2002
    Publication date: January 29, 2004
    Inventors: Karl Y. Hostetler, James R. Beadle, Ganesh D. Kini
  • Antiviral prodrugs
    Patent number: 6002029
    Abstract: Lipid prodrugs of phosphonoacids and their analogs that have increased antiviral activity over the parent drugs in inhibiting cytomegalovirus and other susceptible viruses.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: December 14, 1999
    Inventors: Karl Y. Hostetler, Ganesh D. Kini
  • Immunosuppression by administration of N.sup.6,N.sup.6 -disubstituted cAMP's, analogues thereof, and related nucleosides
    Patent number: 5747474
    Abstract: Methods for inducing immunosuppression in animals which need immunosuppressive treatment involving administration to animals of a therapeutically effective amount of the cyclic AMP agent HE-33 or its nucleoside.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: May 5, 1998
    Assignee: Immune Modulation, Inc.
    Inventors: Emmanuel A. Ojo-Amaize, Howard B. Cottam, Ganesh D. Kini
  • Antiviral prodrugs
    Patent number: 5696277
    Abstract: Lipid prodrugs of phosphonoacids and their analogs that have increased antiviral activity over the parent drugs in inhibiting cytomegalovirus and other susceptible viruses.
    Type: Grant
    Filed: November 15, 1994
    Date of Patent: December 9, 1997
    Assignee: Karl Y. Hostetler
    Inventors: Karl Y. Hostetler, Ganesh D. Kini
  • Antiparasitic 5'-sulfamoyl nucleosides
    Patent number: 4992426
    Abstract: The triazole nucleosides 1-(5'-O-sulfamoyl-.beta.-D-ribofuranosyl)[1,2,4]triazole-3-carboxamide, 1-(5'-O-sulfamoyl-.beta.-D-ribofuranosyl)[1,2,4]triazole-3-thiocarboxamide and 1-(5'-O-sulfamoyl-.beta.-D-ribofuranosyl)[1,2,4]triazole-3-carbonitrile ar e prepared and used as antiparasitic agents.
    Type: Grant
    Filed: February 27, 1989
    Date of Patent: February 12, 1991
    Assignee: Nucleic Acid Research Institute
    Inventors: Roland K. Robins, Ganesh D. Kini
  • Synthesis and anti-leukemic activity of alkyl-1-(.beta.-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates
    Patent number: 4925930
    Abstract: A novel class of alkyl-1-(.beta.-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates of the formula: ##STR1## wherein R.sub.1 is methyl or ethyl and R.sub.2 is .beta.-D-ribofuranosyl, are useful as anti-leukemic agents.
    Type: Grant
    Filed: November 2, 1988
    Date of Patent: May 15, 1990
    Assignee: Nucleic Acid Research Institute
    Inventors: Roland K. Robins, Ganesh D. Kini